Literature DB >> 23000649

Topical thalidomide gel in oral chronic GVHD and role of in situ cytokine expression in monitoring biological activity.

L St John, S M Gordon, R Childs, M Marquesen, S Z Pavletic, T X Wu, T Cozzarelli, E Schroeder, M G Saria, J M Fall-Dickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23000649      PMCID： PMC4214361          DOI： 10.1038/bmt.2012.178

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.

Authors:  D Wang; S D Westerheide; J L Hanson; A S Baldwin
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

2.  Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

Authors:  Howard M Shulman; David Kleiner; Stephanie J Lee; Thomas Morton; Steven Z Pavletic; Evan Farmer; J Margaret Moresi; Joel Greenson; Anne Janin; Paul J Martin; George McDonald; Mary E D Flowers; Maria Turner; Jane Atkinson; Jay Lefkowitch; M Kay Washington; Victor G Prieto; Stella K Kim; Zsolt Argenyi; A Hafeez Diwan; Asif Rashid; Kim Hiatt; Dan Couriel; Kirk Schultz; Sharon Hymes; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2006-01       Impact factor: 5.742

3.  The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus.

Authors:  Nelson L Rhodus; Bin Cheng; Sandra Myers; Lindsay Miller; Vu Ho; Frank Ondrey
Journal:  Mol Carcinog       Date:  2005-10       Impact factor: 4.784

Review 4.  Transplantation's greatest challenges: advances in chronic graft-versus-host disease.

Authors:  Warren D Shlomchik; Stephanie J Lee; Daniel Couriel; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

Review 5.  Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro.

Authors:  E P Sampaio; M O Hernandez; D S Carvalho; E N Sarno
Journal:  Biomed Pharmacother       Date:  2002-02       Impact factor: 6.529

6.  Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.

Authors:  J M Jacobson; J S Greenspan; J Spritzler; L Fox; J L Fahey; J B Jackson; M Chernoff; D A Wohl; J J Pulvirenti; T M Hooton; C Shikuma
Journal:  J Infect Dis       Date:  2000-12-15       Impact factor: 5.226

7.  Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.

Authors:  Rajesh V Lalla; Carol C Pilbeam; Stephen J Walsh; Stephen T Sonis; Dorothy M K Keefe; Douglas E Peterson
Journal:  Support Care Cancer       Date:  2009-04-29       Impact factor: 3.603

Review 8.  [Action mechanism of thalidomide in treatment of multiple myeloma].

Authors:  Shigeru Tsukagoshi
Journal:  Nihon Rinsho       Date:  2007-12
  8 in total
  3 in total

Review 1.  Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective?

Authors:  Bronwen E Shaw
Journal:  Curr Hematol Malig Rep       Date:  2019-02       Impact factor: 3.952

Review 2.  Oral Chronic Graft-Versus-Host Disease.

Authors:  David Dean; Herve Sroussi
Journal:  Front Oral Health       Date:  2022-05-20

Review 3.  Management of oral Graft versus Host Disease with topical agents: A systematic review.

Authors:  Rui Albuquerque; Zahid Khan; Ana Poveda; Jonathan Higham; Andrea Richards; Luis Monteiro; Enric Jané-Salas; José Lopez-Lopez; Saman Warnakulasuriya
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.